{
    "clinical_study": {
        "@rank": "50100", 
        "arm_group": [
            {
                "arm_group_label": "Oral glucose tolerance test", 
                "arm_group_type": "Active Comparator", 
                "description": "The participants will consume a beverage containing 75 gram glucose During the meeting, the participants will drink the sweetened drink followed by blood work, at 0, 30, 60, 120, 180 minutes. Also, they will record their macronutrient\\caloric consumption during the 24 hour following the test."
            }, 
            {
                "arm_group_label": "Artificial sweetner", 
                "arm_group_type": "Placebo Comparator", 
                "description": "participants will consume a beverage containing 0.42 gram artificial sweetener (Aspartame) During each meeting, the participants will drink the sweetened drink followed by blood work, at 0, 30, 60, 120, 180 minutes.\nAlso, they will record their macronutrient\\caloric consumption during the 24 hour following the test."
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of this study is to determine the hormonal/metabolic reponse to ingestion of sugar\n      compared to consuming artificial sweetened drink, and to evalute macronutrient consumption\n      24 hours post ingestion of the drinks.\n\n      We hypothesize that artificially sweetened (AS) consumption will lead to a relatively\n      similar hormonal/metabolic responses as glucose consumption and therefore to secondary rise\n      of caloric intake."
        }, 
        "brief_title": "The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "detailed_description": {
            "textblock": "During the last two decades, the prevalence of overweight and obesity doubled. at the same\n      time, individuals have increasingly turned to artificially sweetened (AS) foods and\n      beverages in an attempt to lose weight, or control it.\n\n      several studies have found that there may be a connection between artificially sweetened\n      food and beverages consumption  and  paradoxical  weight gain and  increased incidence of\n      metabolic syndrome. the causal relationship between AS use and weight gain haven't been\n      proven yet.\n\n      The participants will be invited to 2 meetings in which they will consume, in a randomized\n      double blind way:\n\n        1. A beverage containing 75 gram glucose\n\n        2. A beverage containing 0.42 gram artificially sweetener (Aspartame, similar sweetness\n           level)\n\n      During each meeting, the participants will drink the sweetened drink followed by blood work,\n      as done in oral glucose challenge or tolerance test (OGTT / GTT).\n\n      Also, they will record their macronutrient\\caloric consumption during the 24 hour following\n      the test."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults, healthy, men and women, ages 25-35 years, without any chronic illnesses.\n\n        Exclusion Criteria:\n\n          -  Family history of diabetes or overweight with BMI> 27\n\n          -  Use of drugs who can influence the glucose metabolism (exp: glucocorticoids)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683929", 
            "org_study_id": "MeirMc017112CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Oral glucose tolerance test", 
                "description": "The participants will report to the lab after an overnight fast. Their BMI, HR and BP will be measured. An  IV catheter will be inserted  into the brachial vein and the participants will rest for half an hour. Participants will drink A beverage containing 75 gram glucose (oral glucose tolerance test (OGTT / GTT) All the participants will be checked for level of: insulin, glucose, adrenalin norepinephrine, dopamine, catecholamines, cortisol, ghrelin, leptin, IGF-1 GH and other related hormones- before consuming the drink (time 0), and at 30, 60, 120, 180 minutes after.\nThe participants HR & BP will be monitored throughout the examination + 1 hour after.\nIn addition, the participants will be asked to complete a- \"24 hr food questionnaire\".", 
                "intervention_name": "glucose", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Artificial sweetner", 
                "description": "The participants will report to the lab after an overnight fast. Their BMI, HR and BP will be measured. An  IV catheter will be inserted  into the brachial vein and the participants will rest for half an hour. Participants will drink A beverage containing artificial sweetened drink. All the participants will be checked for level of: insulin, glucose, adrenalin norepinephrine, dopamine, catecholamines, cortisol, ghrelin, leptin, IGF-1 GH and other related hormones- before consuming the drink (time 0), and at 30, 60, 120, 180 minutes after.\nThe participants HR & BP will be monitored throughout the examination + 1 hour after.\nIn addition, the participants will be asked to complete a- \"24 hr food questionnaire\".", 
                "intervention_name": "sweetner", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obesity", 
            "Overweight", 
            "Sugar consumption", 
            "Metabolic syndrome", 
            "Artificially sweetened foods and beverages"
        ], 
        "lastchanged_date": "May 11, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Dan.Nemet@clalit.org.il", 
                    "last_name": "Dan Nemet, MD", 
                    "phone": "972-9-7471596"
                }, 
                "facility": {
                    "address": {
                        "city": "Kfar Saba", 
                        "country": "Israel"
                    }, 
                    "name": "Meir Medical Center"
                }, 
                "investigator": {
                    "last_name": "Dan Nemet, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Dan.Nemet@clalit.org.il", 
                    "last_name": "Dan Nemet, MD", 
                    "phone": "972-9-7471596"
                }, 
                "facility": {
                    "address": {
                        "city": "Kfar-Saba", 
                        "country": "Israel"
                    }, 
                    "name": "Meir Medical Center"
                }, 
                "investigator": {
                    "last_name": "Dan Nemet, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses and 24 Hour Macronutrient Consumption - A Double Blind, Cross-over Study", 
        "overall_contact": {
            "email": "Dan.Nemet@clalit.org.il", 
            "last_name": "Dan Nemet, MD", 
            "phone": "972-9-7471596"
        }, 
        "overall_official": {
            "affiliation": "Meir Medical Center, Kfar-Saba, Israel", 
            "last_name": "Dan Nemet, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "All the participants will be checked for level of: insulin, glucose, adrenalin norepinephrine, dopamine, catecholamines, cortisol, ghrelin, leptin, IGF-1 GH- and other related hormones before consuming the drink (time 0), and 30, 60, 120, 180 minutes after.\nThe participants will be under medical supervision throughout the examination, including HR & BP montoring, and until 1 hour after", 
            "measure": "Hormonal response", 
            "safety_issue": "No", 
            "time_frame": "3 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683929"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The participants will be receiving a- \"24 hr food questionnaire\" which they will fill during the day after consuming the drink followed by an  interview in order to get the maximal information.", 
            "measure": "food questionnaire", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Meir Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meir Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}